Functionally, abolishing the acetylation of KIAA1429 at the K156 site inhibited PD-L1, and TIP60-mediated KIAA1429 acetylation promoted PD-L1-mediated HCC cell immune evasion. Here, KAT5 is linked to hepatocellular carcinoma.